Michael Ramcharan (Reumat Consulting Ltd) has over 30 years of experience in Quality Assurance having worked with multinational Pharmaceutical and Clinical Research Organisations (CRO) mainly in the GCP and GPV areas. He has conducted a wide variety of audits (both On-site and Remote) globally, and managed various risk-based audit programmes. He has also hosted and supported many European Regulatory Authority Inspections (eg; MHRA, EMA, Local EU country Inspectorates).
Opening remarks setting the context for Pharmacovigilance World 2026, outlining the key themes, regulatory landscape, and objectives for the conference. Setting expectations for learning, networking, and practical takeaways over two days
Michael Ramcharan
Managing Director at Reumat Consulting
How leading organisations are embedding pharmacovigilance into decision-making, culture, and strategy - moving from reactive compliance to proactive patient safety.
Michael Ramcharan
Managing Director at Reumat Consulting
Ivana Hezoucky
Regional Patient Safety Manager at Boehringer Ingelheim
Judy Barretto
Senior Director at Gilead Sciences
Sandra Reda
Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals
Brian Edwards
Managing Director at Husoteria Ltd
End of Day 1 with the Chairperson's closing remarks and summarising key insights
Michael Ramcharan
Managing Director at Reumat Consulting
Opening remarks outlining the focus of Day 2 on technology, data, automation, and future pharmacovigilance operating models.
Michael Ramcharan
Managing Director at Reumat Consulting
A discussion on how leadership in pharmacovigilance is evolving in response to increasing data, regulatory expectations, and technological change.
Michael Ramcharan
Managing Director at Reumat Consulting
Puja Myles
Director, Clinical Practice Research Datalink at Medicines and Healthcare products Regulatory Agency
Joanne Rogerson
Director of Operations at Resolver
Sandra Reda
Senior Pharmacovigilance Specialist at Newbridge Pharmaceuticals
Jean-Marc C. Haeusler
Global Head International Patient Safety at Roche
Aliki Taylor
Executive Director, RWE TA Head - Oncology at Gilead Sciences
End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.
Michael Ramcharan
Managing Director at Reumat Consulting
For general conference and registration enquires please contact the below email id or via call
Login 
Tuesday - June 16, 2026
08:50
AM -
09:00
AM 
10
Minutes
info@corvusglobalevents.com
+44
(0)
207
096 0786
